SHAIK, MOHAMMED MONSOOR
 Distribuzione geografica
Continente #
EU - Europa 2.789
AS - Asia 1.376
NA - Nord America 987
SA - Sud America 194
AF - Africa 40
OC - Oceania 3
Totale 5.389
Nazione #
SE - Svezia 1.869
US - Stati Uniti d'America 946
IT - Italia 452
SG - Singapore 422
CN - Cina 277
VN - Vietnam 195
HK - Hong Kong 175
BR - Brasile 140
RU - Federazione Russa 131
IN - India 66
GB - Regno Unito 56
FR - Francia 53
DE - Germania 41
KR - Corea 41
BD - Bangladesh 38
JP - Giappone 27
FI - Finlandia 26
IE - Irlanda 26
PL - Polonia 26
ES - Italia 24
ID - Indonesia 23
NL - Olanda 22
TR - Turchia 20
AR - Argentina 19
CA - Canada 18
PK - Pakistan 16
DK - Danimarca 15
IQ - Iraq 14
ZA - Sudafrica 14
MX - Messico 13
CL - Cile 10
BE - Belgio 9
AT - Austria 8
MA - Marocco 8
SA - Arabia Saudita 8
UA - Ucraina 8
CO - Colombia 7
EC - Ecuador 7
MY - Malesia 7
PH - Filippine 7
UZ - Uzbekistan 7
IL - Israele 6
VE - Venezuela 6
LB - Libano 5
AE - Emirati Arabi Uniti 4
KE - Kenya 4
PT - Portogallo 4
AU - Australia 3
AZ - Azerbaigian 3
CH - Svizzera 3
ET - Etiopia 3
LT - Lituania 3
NP - Nepal 3
PY - Paraguay 3
AL - Albania 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
GA - Gabon 2
JM - Giamaica 2
JO - Giordania 2
KG - Kirghizistan 2
MK - Macedonia 2
PA - Panama 2
RO - Romania 2
TN - Tunisia 2
AM - Armenia 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CY - Cipro 1
KH - Cambogia 1
KZ - Kazakistan 1
LV - Lettonia 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TG - Togo 1
Totale 5.389
Città #
Stockholm 1.866
Singapore 271
Hong Kong 164
Milan 164
San Jose 160
Ashburn 132
Ho Chi Minh City 67
Hefei 64
Los Angeles 63
Hanoi 56
Santa Clara 48
Seoul 38
New York 36
Beijing 34
Council Bluffs 34
Dallas 32
Chicago 28
Dublin 27
Tokyo 26
Buffalo 25
São Paulo 25
Helsinki 20
Frankfurt am Main 18
Jakarta 18
Shanghai 18
Warsaw 18
Amsterdam 16
Rome 16
Hyderabad 14
Paris 13
The Dalles 13
Bologna 12
Chennai 12
Washington 12
Copenhagen 11
Lauterbourg 11
Orem 11
Johannesburg 10
London 10
Brescia 9
Denver 9
Florence 9
Houston 9
Desio 8
Nuremberg 8
Atlanta 7
Barnet 7
Haiphong 7
Hangzhou 7
Montreal 7
Poplar 7
Sorbolo 7
Tashkent 7
Turin 7
Baghdad 6
Boardman 6
Brooklyn 6
Dhaka 6
Istanbul 6
Moscow 6
Philadelphia 6
Santiago 6
Toronto 6
Boston 5
Da Nang 5
Guangzhou 5
Kent 5
Krakow 5
Kuala Lumpur 5
Lappeenranta 5
Mumbai 5
Naples 5
New Delhi 5
Pisogne 5
San Giuliano Terme 5
Vienna 5
Berlin 4
Bexley 4
City of London 4
Como 4
Edinburgh 4
Heverlee 4
Inzago 4
Medellín 4
Mexico City 4
Monza 4
Munich 4
Nairobi 4
Phoenix 4
Saint-Martin-d'Hères 4
Salò 4
San Francisco 4
Sarnico 4
Seregno 4
Sesto San Giovanni 4
Addis Ababa 3
Aksaray 3
Ankara 3
Baku 3
Belém 3
Totale 3.938
Nome #
Representative secondary PET micro and nanoplastics via ethylene glycol fragmentation (EGF): Physicochemical and immuno-toxicological properties 1.932
Vibrational spectroscopy coupled with machine learning sheds light on the cellular effects induced by rationally designed TLR4 agonists 341
New Glucosamine-Based TLR4 Agonists: Design, Synthesis, Mechanism of Action, and In Vivo Activity as Vaccine Adjuvants 286
Study on the impact of Toll-like Receptor 4 (TLR4) modulation in rare inflammatory-fibrotic diseases 282
Impact of Toll-like Receptor 4 (TLR4) chemical modulation by small- molecular antagonists in rare inflammatory-fibrotic diseases 269
Design, Synthesis and characterization of synthetic and natural derived TLR4 antagonists 251
Towards more efficient synthetic immunomodulators: biological characterization and mechanism of action of monosaccharide-derived TLR4 agonists 243
Novel TLR4-Activating Vaccine Adjuvant Enhances the Production of Enterococcus faecium-binding Antibodies 239
Overcoming Challenges in Chemical Glycosylation to Achieve Innovative Vaccine Adjuvants Possessing Enhanced TLR4 Activity 222
Development of a New Vaccine Adjuvant System Based on the Combination of the Synthetic TLR4 Agonist FP20 and a Synthetic QS-21 Variant 203
Emerging Extracellular Molecular Targets for Innovative Pharmacological Approaches to Resistant Mtb Infection 194
Self-Activated Fluorescent Hydroxyapatite Nanoparticles: A Promising Agent for Bioimaging and Biolabeling 167
Ellagic acid containing collagen-chitosan scaffolds as potential antioxidative bio-materials for tissue engineering applications 149
Antioxidant-antibacterial containing bi-layer scaffolds as potential candidates for management of oxidative stress and infections in wound healing 144
Novel melt-down neutralization method for synthesis of chitosan-silver scaffolds for tissue engineering applications 140
Study on the impact of Toll-like Receptor 4 (TLR4) modulation in rare inflammatory-fibrotic diseases 106
Developing New Toll-Like Receptor 4 (TLR4) Modulators As Innovative And Inexpensive Vaccine Adjuvants 59
Developing New Toll-Like Receptor 4 (TLR4) Modulators as Innovative and Inexpensive Vaccine Adjuvants 39
Design, synthesis and Biological evaluation of New, glycolipid-based Toll-Like Receptor 4 (TLR4) Modulators 37
Design, Synthesis and Biological Evaluation of New Glycolipid-Based Toll-Like Receptor 4 (TLR4) Modulators 35
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW, GLYCOLIPID-BASED TOLL-LIKE RECEPTOR 4 (TLR4) MODULATORS 35
Design, synthesis and Biological evaluation of New, glycolipid-based Toll-Like Receptor 4 (TLR4) Modulators 35
Design, synthesis and Biological evaluation of New, glycolipid-based Toll-Like Receptor 4 (TLR4) Modulators 32
Design, synthesis and Biological evaluation of New, glycolipid-based Toll-Like Receptor 4 (TLR4) Modulators 32
Totale 5.472
Categoria #
all - tutte 12.839
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.839


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202330 0 0 0 0 0 0 0 0 0 18 7 5
2023/2024226 1 7 48 18 12 23 27 2 22 18 17 31
2024/2025989 29 66 95 62 68 52 60 33 77 149 85 213
2025/20264.227 229 141 153 285 234 110 332 129 273 2.200 120 21
Totale 5.472